Justin Bowers
Stock Analyst at Deutsche Bank
(0.88)
# 3,750
Out of 4,423 analysts
142
Total ratings
43%
Success rate
-2%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintained: Buy | $72 → $66 | $57.94 | +13.91% | 8 | May 8, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $17 → $23 | $34.76 | -33.82% | 9 | May 8, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Buy | $10 → $6 | $5.20 | +15.38% | 6 | May 8, 2026 | |
| CON Concentra Group Holdings Parent | Maintained: Buy | $29 → $32 | $28.56 | +12.04% | 2 | May 8, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $350 | $355.44 | -1.53% | 10 | May 7, 2026 | |
| FTRE Fortrea Holdings | Maintained: Hold | $14 | $15.31 | -8.56% | 6 | May 7, 2026 | |
| SEM Select Medical Holdings | Downgraded: Hold | $50 → $17 | $16.54 | -0.24% | 23 | Mar 4, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $345 → $315 | $327.95 | -3.95% | 6 | Feb 13, 2026 | |
| DHR Danaher | Maintained: Buy | $270 | $177.17 | +52.40% | 10 | Jan 29, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $630 → $620 | $464.61 | +33.45% | 9 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $185 | $185.00 | - | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $167.77 | +31.13% | 16 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $336 → $430 | $460.20 | -6.56% | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 → $175 | $132.02 | n/a | 8 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $9.58 | n/a | 6 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 → $370 | $146.00 | n/a | 7 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $70 | $98.03 | n/a | 1 | Sep 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $161.93 | n/a | 1 | Jan 17, 2014 |
Bio-Techne
May 8, 2026
Maintained: Buy
Price Target: $72 → $66
Current: $57.94
Upside: +13.91%
10x Genomics
May 8, 2026
Maintained: Hold
Price Target: $17 → $23
Current: $34.76
Upside: -33.82%
Maravai LifeSciences Holdings
May 8, 2026
Maintained: Buy
Price Target: $10 → $6
Current: $5.20
Upside: +15.38%
Concentra Group Holdings Parent
May 8, 2026
Maintained: Buy
Price Target: $29 → $32
Current: $28.56
Upside: +12.04%
Waters
May 7, 2026
Maintained: Hold
Price Target: $330 → $350
Current: $355.44
Upside: -1.53%
Fortrea Holdings
May 7, 2026
Maintained: Hold
Price Target: $14
Current: $15.31
Upside: -8.56%
Select Medical Holdings
Mar 4, 2026
Downgraded: Hold
Price Target: $50 → $17
Current: $16.54
Upside: -0.24%
West Pharmaceutical Services
Feb 13, 2026
Maintained: Buy
Price Target: $345 → $315
Current: $327.95
Upside: -3.95%
Danaher
Jan 29, 2026
Maintained: Buy
Price Target: $270
Current: $177.17
Upside: +52.40%
Thermo Fisher Scientific
Oct 23, 2025
Maintained: Buy
Price Target: $630 → $620
Current: $464.61
Upside: +33.45%
Aug 7, 2025
Maintained: Buy
Price Target: $180 → $185
Current: $185.00
Upside: -
Jul 29, 2025
Maintained: Buy
Price Target: $260 → $220
Current: $167.77
Upside: +31.13%
Jul 23, 2025
Maintained: Hold
Price Target: $336 → $430
Current: $460.20
Upside: -6.56%
Aug 16, 2024
Maintained: Buy
Price Target: $155 → $175
Current: $132.02
Upside: n/a
Jul 26, 2024
Maintained: Hold
Price Target: $25
Current: $9.58
Upside: n/a
Jul 24, 2024
Maintained: Buy
Price Target: $300 → $370
Current: $146.00
Upside: n/a
Sep 16, 2019
Initiated Coverage: Hold
Price Target: $70
Current: $98.03
Upside: n/a
Jan 17, 2014
Maintained: Buy
Price Target: $140
Current: $161.93
Upside: n/a